A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects

NCT02958436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN3500
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]